Challenges in Recruiting Patients to a Controlled Feasibility Study of a Drug for Opioid-Induced Constipation: Lessons From the Population With Advanced Cancer
- 1 May 2019
- journal article
- letter
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 57 (5) , e5-e8
Abstract
No abstract availableFunding Information
- AstraZeneca
- Pharmaceuticals LP
This publication has 6 references indexed in Scilit:
- Using the ‘Social Marketing Mix Framework’ to explore recruitment barriers and facilitators in palliative care randomised controlled trials? A narrative synthesis reviewPalliative Medicine, 2018
- What Is New in Rome IVJournal of Neurogastroenterology and Motility, 2017
- NaloxegolAnnals of Pharmacotherapy, 2014
- Randomised clinical trial: the long‐term safety and tolerability of naloxegol in patients with pain and opioid‐induced constipationAlimentary Pharmacology & Therapeutics, 2014
- Naloxegol for Opioid-Induced Constipation in Patients with Noncancer PainNew England Journal of Medicine, 2014
- Changes in the Quantity and Level of Evidence of Palliative and Hospice Care Literature: The Last CenturyJournal of Clinical Oncology, 2008